Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement
Hepatic Medicine: Evidence and Research · 2017-10 · Volume 9 · 45-53
DOI: 10.2147/hmer.s142600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatic Medicine: Evidence and Research, 2017-10. Verfasst von Mohammed Tag-Adeen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Qena School of Medicine, South Valley University, Qena, Egypt. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Qena School of Medicine, South Valley University, Qena, Egypt.
- Department of Gastroenterology and Hepatology, Nagasaki School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Zitieren
APA
Tag-Adeen, M., Sabra, A. M., Akazawa, Y., Ohnita, K., & Nakao, K. (2017). Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement. Hepatic Medicine: Evidence and Research, Volume 9, 45-53. https://doi.org/10.2147/hmer.s142600
Vancouver
Tag-Adeen M, Sabra AM, Akazawa Y, Ohnita K, Nakao K. Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement. Hepatic Medicine: Evidence and Research. 2017;Volume 9:45-53. doi:10.2147/hmer.s142600
BibTeX
@article{TagAdeen2017,
author = {Tag-Adeen, Mohammed and Sabra, Ahlam Mohamed and Akazawa, Yuko and Ohnita, Ken and Nakao, Kazuhiko},
title = {Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement},
journal = {Hepatic Medicine: Evidence and Research},
year = {2017},
volume = {Volume 9},
pages = {45--53},
doi = {10.2147/hmer.s142600}
}
EUVIMED